American Society of Hematology

Late-Breaking Abstract Submission

The deadline for late-breaking abstract submission is October 30, 2017, at 11:59 p.m. PDT.

2018 Highlights of ASH

Attend one of eight Highlights of ASH meetings featuring expert analysis of stand-out abstracts and sessions from the 59th ASH Annual Meeting.

Learn more

Clinical Research Training Institute in Latin America

Strengthen the fundamental skills needed to become a successful patient-oriented clinical leader. Apply by October 30!

Learn more

59th ASH Annual Meeting

December 9-12, 2017, Atlanta, GA

2018 Highlights of ASH^®North America | Asia-Pacific | Latin America

View all meetings

October 30, 2017
Application Deadline for Clinical Research Training Institute in Latin America
November 15, 2017
Request a Mentor Deadline for the Minority Medical Student Award Program

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more

ASH Membership

Become part of a global network of more than 17,000 hematologists working to conquer blood diseases.

Learn more

Press Releases
Policy News
The Hematologist

Press Release Rotator Test
ASH Supports Promising Biomedical Research of Five Investigators through ASH Bridge Grant Program
ASH announced the names of five investigators whose research has been awarded $150,000 through the ASH Bridge Grant Program.
Engineered Therapy for Blood Clotting Disorder Shows Early Promise
New data indicates that an investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with the rare, life-threatening blood disease hereditary thrombotic thrombocytopenic purpura.
ASH President Comments on FDA Approval of First CART-Cell Therapy to Treat Childhood Leukemia
ASH's President issued this response to today's approval by the U.S. FDA of the first chimeric antigen receptor (CAR) T-cell therapy for the treatment of children with relapsed/treatment-resistant CD-19 positive acute lymphocytic leukemia (ALL).

View all press releases

ASH Issues Recommendations for Pediatric Research Questions to NIH’s All of Us Research Program
ASH submitted comments to the NIH on hematology-related pediatric research that should be included in the NIH's All of Us research program.
What’s next for the ACA?
After spending months crafting legislation to repeal and replace the Affordable Care Act (ACA), in late July, the U.S. Senate had its chance to vote on and pass repeal legislation.
NCATS Seeking Information on Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases
The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases.
Congress Changes Stance on ACA Repeal and Replace
On July 13, 2017, the U.S. Senate released an updated version of the Better Care Reconciliation Act (BCRA), legislation to repeal large provisions of the Affordable Care Act (ACA).

View all policy news

Test deletion 3
Test title November 14, 2017
Summary
A Woman With Hypergammaglobulinemia and Diffuse Lymphadenopathy
Take the image challenge to determine the diagnosis for a woman with hypergammaglobulinemia and diffuse lymphadenopathy.
How We Mark Time and How Time Marks Us
Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.

View all Hematologist articles

American Society of Hematology

Late-Breaking Abstract Submission

2018 Highlights of ASH

Clinical Research Training Institute in Latin America

59th ASH Annual Meeting

Research

Education

Meetings & Dates

Application Deadline for Clinical Research Training Institute in Latin America

Request a Mentor Deadline for the Minority Medical Student Award Program

Find a Hematologist

ASH Foundation

ASH Membership

Press Release Rotator Test

ASH Supports Promising Biomedical Research of Five Investigators through ASH Bridge Grant Program

Engineered Therapy for Blood Clotting Disorder Shows Early Promise

ASH President Comments on FDA Approval of First CART-Cell Therapy to Treat Childhood Leukemia

ASH Issues Recommendations for Pediatric Research Questions to NIH’s All of Us Research Program

What’s next for the ACA?

NCATS Seeking Information on Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases

Congress Changes Stance on ACA Repeal and Replace

Test deletion 3

Test title November 14, 2017

A Woman With Hypergammaglobulinemia and Diffuse Lymphadenopathy

How We Mark Time and How Time Marks Us